Because Tau and Aβ dysregulation are the hallmarks of AD pathogenesis, we hypothesized that AA AD-associated coding mutations in AKAP9 might alter the activation status of PKA and increase phosphorylation of the Tau protein and Aβ production. Here, MAPT is linked to Alzheimer disease.